S02 Sources Sought 36C25621Q1626 Glove Gown Sampling USP Testing.pdf

SUBJECT* Glove Gown Sampling, USP (and other related) Testing, Gulf Coast Veterans Health Care System, Pharmacy Department Biloxi, MS 39531 / Pensacola FL 32507

GENERAL INFORMATION

CONTRACTING OFFICE’S ZIP CODE* 39531

SOLICITATION NUMBER* 36C25621Q1626

RESPONSE DATE/TIME/ZONE 08-16-2021 1300 EASTERN TIME, NEW YORK,

USA

ARCHIVE 99 DAYS AFTER THE RESPONSE DATE

RECOVERY ACT FUNDS N

SET-ASIDE

PRODUCT SERVICE CODE* Q301

NAICS CODE* 541380

CONTRACTING OFFICE ADDRESS Department of Veterans Affairs

Gulf Coast Veterans Health Care System Network Contracting Office 16 400 Veterans Avenue Biloxi MS 39531

POINT OF CONTACT*

C. Robert Oravetz, Contract Specialist Department of Veterans Affairs christopher.oravetz@va.gov Gulf Coast Veterans Health Care System 400 Veterans Avenue Biloxi, MS 39531

PLACE OF PERFORMANCE

ADDRESS Department of Veterans Affairs Gulf Coast Veterans Health Care System Pharmacy Services 400 Veterans Avenue & 790 Veterans Way Biloxi, MS 39531 / Pensacola, FL 32507

POSTAL CODE

COUNTRY USA

ADDITIONAL INFORMATION

AGENCY’S URL https://www.va.gov/ URL DESCRIPTION VA website AGENCY CONTACT’S EMAIL ADDRESS christopher.oravetz@va.gov EMAIL DESCRIPTION CO Email Address mailto:christopher.oravetz@va.gov

Glove Gown Sampling, USP (and other related) Testing Gulf Coast Veterans Health Care System

Pharmacy Department 400 Veterans Avenue

Biloxi, MS 39531

The Gulf Coast Veterans Health Care System located at 400 Veterans Avenue Biloxi; MS 39531 is seeking a contractor to support the following requirement: Glove Gown Sampling, USP (and other related) Testing. This requirement is for testing of all the Gulf Coast Veterans Health Care System (GCVHCS) facility’s sterile clean rooms and segregated compounding areas used for preparation of Compounded Sterile Preparations (CSPs) as well as staff competency testing.

The applicable NAICS code for this procurement is 541380-Testing Laboratories. The associated size standard is $16.5 million.

**For all performance periods of the proposed contract services execution and tasks/deliverables completion shall be done IAW United States Pharmacopeia (USP) and CETA certification requirements. This includes directives contained in USP 797 (2019) Highlight and VA Directive

1108.12 CETA Highlight. All work, execution of services, and completion of task/deliverables must be completed by trained & certified technicians possessing the required competencies.

USP 797 (2019) Highlight and VA Directive 1108.12 CETA Highlight are provided with this notice.

Instruction to Offerors Guidance:

This sources sought notice is not a Request for Quote (RFQ) or a Request for Proposal (RFP) and no solicitation is being issued at this time. This notice shall not be construed as a commitment by the Government to issue a solicitation or to ultimately award a contract, nor does it restrict the government to a specific acquisition approach which includes a specific set aside for that approach.

Any information provided to the Government as a result of this sources sought notice is strictly voluntary. Responses will not be returned. No entitlement to payment for direct and/or indirect costs or charges by the Government will arise as a result of contractor submission of responses or the Government’s use of such information.

This Sources Sought Notice is for market research and planning purposes only. This notice is intended to identify eligible contractors in any socioeconomic category who can support this requirement. An eligible contractor is defined as a contractor who possesses the technical knowledge, skills, abilities, qualifications, capability, and relevant experience to meet or exceed the government’s requirements as annotated in the Statement of Work (SOW) (and/or in other associated documents).

Instructions for Submission:

Interested, eligible contractors shall respond by e-mail only to C. Robert Oravetz, Contract Specialist, christopher.oravetz@va.gov. Responses are due no later than Monday, August 16th, 2021 by 1300 hours (1:00 p.m.) Eastern Time.

mailto:christopher.oravetz@va.gov

Respondents shall include as part of their submission:

a. Indicate if you can meet or exceed the government’s requirements to provide Glove Gown Sampling, USP (and other related) Testing services for the Gulf Coast Veterans Health Care System.

• Eligible contractors must be able to perform the work, meet the requirements, and execute the required tasks and deliverables (with the appropriate trained & certified personnel) as described in all sections of the Statement of Work which includes adhering to the guidelines contained within USP 797 (2019) Highlight and VA Directive

1108.12 CETA Highlight.

A summary/overview of your skills, abilities, capabilities, qualifications, relevant experience, and relevant past contracts and/or or past projects (as it directly relates to this requirement) must be included in your response to this notice. Merely stating that you are a contractor who is interested in this requirement (without providing any supporting details and/or documentation to verify your capabilities and qualifications) will not be considered as an adequate response/submission to this notice.

b. A future solicitation for this requirement will be “all or nothing” meaning that the Contractor will have to provide all services, tasks, and deliverables that have been requested. Please do not submit a price quote/price proposal as this request is for market research and informational purposes only. Please refer to the section in this notice entitled TASKS/DELIVERABLES “PUNCH LIST” which describes the government’s specific requirements (i.e. line items) that will be needed during all performance periods.

REQUIREMENT QUESTIONS:

If/when this requirement is solicited there will only be a limited time window to address contractor solicitation questions. It is recommended that interested, eligible contractors (who are examining this notice and who have questions) submit these questions along with their response to this notice. The submission of questions by contractors is encouraged as it will allow the government to further define and clarify this procurement if there is ambiguity.

The following documents are contained within (or accompany) this Sources Sought Notice:

1). P09 Final SOW Glove Gown Sampling USP Testing 2). Task Deliverables-Line Items All Performance Periods 3). USP 797 (2019) Highlight 4). VA Directive 1108.12 CETA Highlight

See subsequent pages to follow and documents attached.

STATEMENT OF WORK

Glove Gown Sampling and USP (and related) Testing Gulf Coast Veterans Health Care System / Pharmacy

400 Veterans Avenue Biloxi, MS 39531

07/29/2021

STATEMENT OF WORK PART A – GENERAL INFORMATION

A.1 INTRODUCTION: This requirement is for testing of all the Gulf Coast Veterans Health Care System (GCVHCS) facility’s sterile clean rooms and segregated compounding areas used for preparation of Compounded Sterile Preparations (CSPs) as well as staff competency testing. Testing will be completed in accordance with United States Pharmacopeia (USP) Chapter <797>, or current guidelines.

A.2 BACKGROUND: GCVHCS is pursuing a contract for standardizing testing criteria appropriate sterile compounding areas used pursuant to current USP Chapter <797> and Chapter <800> standards using Controlled Environment Testing Association (CETA) Certified National Board of Testing (CNBT) certified individuals to establish consistent procedures using the Certification Guide for Sterile Compounding Facilities CAG-009-00. Depending on the period of performance and option year(s), testing procedures shall be maintained in compliance with all current applicable USP standards.

The USP establishes standards for cleanroom design, environmental monitoring, and competencies for the preparation, handling, and storage of CSPs. The Joint Commission (TJC) Accreditation Manual for Home Care, effective January 13, 2018, established new Medication Compounding (MC) standards for non-sterile and sterile compounded preparations which are based on USP standards. The Food and Drug Administration (FDA) has the authority to inspect VA medical facilities under the Draft Guidance on “Insanitary Conditions at Compounding Facilities” which was published in August 2016.

Certification procedures defined in CETA CAG-009-00 shall be performed by a CETA National Board of Testing (CNBT) certified testing individual no less than every month.

A.3 SCOPE OF WORK:

The contractor shall complete viable sampling according to USP <797> (and <800> after December 1, 2019) using certification procedures from the Controlled Environment Testing Association (CETA) Certification Guides for Sterile Compounding Facilities (CAG-009-00).

The list of tests, depending on CETA and manufacturer guidance for the type of PEC, includes, but is not limited to:

• Viable particle counts under dynamic operating conditions

• Surface sampling

A.3.1 All CSP Facilities must be tested according to CETA CAG-009-00 specifications. The contractor will provide comprehensive cleanroom testing services with frequency required by most current USP <797> standards (and USP <800> after December 1, 2019). Test equipment used will be clean, in good working order and calibrated on a calibration frequency not to exceed 12 months or more frequently if recommended by the manufacturer. Calibration certificates should be provided upon request by the facility POC for all calibrated test equipment. USP Compliance Testing for Cleanrooms and Controlled Environment certification will include but is not limited to the following:

• Viable / Microbial Air Testing

• Viable / Microbial Surface Testing

A3.1.1 Viable particle counts samples will be collected in accordance with applicable CETA guides. Viable samples will be collected for each device (both bacterial and fungal) for the air and surface in accordance with USP <797> (and <800> after December 1, 2019).

A.3.1.2 Viable Environmental Sampling

• The contractor shall perform viable environmental (air) sampling every month for fungi and bacteria using high volume impaction samplers to conduct the sampling.

• In addition, viable environmental surface sampling of classified areas will be performed When conducted, surface sampling must be performed at the end of the compounding activities or shift, but before the area has been cleaned and disinfected. Sampling must include the following areas:

• The interior of the PEC and the equipment contained in it

• Staging or work area(s) near the PEC

• Frequently touched surfaces

• Positive and Negative controls for each media type and lot number will be included

• Chain of Custody will be documented for each sample.

• Locations of sampling will be determined by the facility’s environmental sampling plan

• Samples are taken while the cleanroom is in a dynamic operating state as defined by CETA.

• Air sampling: A sufficient volume of air (1000 liters) shall be tested at each location by impaction method in order to maximize sensitivity. Samples of less than 1000 liters will not be acceptable.

• Surface Sampling: The contractor shall perform surface samples for bacteria using Tryptic Soy Agar

(TSA) contact plates and Malt Extract Agar (MEA) or Sab DEX contact plates for sampling of fungi.

Surface sampling must be performed at the end of the compounding activities or shift, but before the area has been cleaned and disinfected.

A.3.1.3 Testing Report Report Requirements: Results of the certification process will be documented in accordance with CETA guides. All of the following information will be included in the report. Pass/Fail notifications should be included on a per-test basis where applicable.

Reports to include at a minimum:

• Name, address and contact information for the certifying organization

• Name and accreditation of personnel performing tests

• Confirming remark that the most current version of CETA CAG was referenced for the certification.

• Executive summary or summary of findings

• Room number and/or location

• Room type (e.g. oncology buffer room)

• Type of PEC tested

• Serial number of the PEC tested

• Standards used to test room and justification for any deviations from established industry practices encountered during the certification process.

• Details of each test conducted or SOP referenced

• Acceptance criteria for each test

• Test equipment used with calibration date

• Viable particle count analysis o Sketch of viable particle test location in room o Viable sample results (CFU’s), action level for target ISO level o Identification of all recovered organisms at least to genus level o The identification of highly pathogenic microorganisms will be highlighted in the report.

o Certificates of analysis of all growth media used

• Comments indicating when dynamic operating conditions were used

A.3.1.4 Report Distribution The contractor will immediately notify identified points of contact with any results indicating failure. A formalized written report including all required aspects specified in this Statement of Work will be provided in a timely manner with receipt by identified points of contact no more than 14 days from certification evaluation.

All completed reports will be provided via email to Elizabeth.beatty@va.gov, linda.seely@va.gov, and Nicole.patterson1@va.gov.

Contractor will be notified by facility of any updates to identified points of contact list on an as needed basis.

A3.1.5 Testing Frequency:

• Environmental air sampling will be completed monthly or more frequently if required to assess corrective actions associated with prior negative results. Viable surface sampling will be conducted monthly. More frequent testing may be required should USP standards change during the performance period or option year(s).

A3.2 Staff competency testing:

All testing must be in accordance with USP <797> (and <800> after December 1, 2019) and CETA CAG-009- 00 requirements. The contractor shall furnish all supplies, equipment, labor, shipping, travel, and any other services necessary to accomplish these needs. The sampling will include the total counts and Genus of the organism. Sampling will take place during normal business hours: Monday through Friday (Time: 8:00 a.m.

to 4:30 p.m. CST) excluding federal holidays.

All employees will complete a Media Fill Test (MFT) using soybean-casein digest media initially upon hiring at least every 6 months. Additional testing may be required as needed to address possible failures. Manipulation of MFT must be done in a manner that simulates the most difficult compounding completed by each employee.

The initial Glove Tip Sampling for bacterial and fungal, shall be performed after the employee performs complete hand hygiene and garbing procedures 3 separate times for each hand. Positive and Negative controls will be submitted to the lab for analysis.

Glove Tip Sampling (bacterial and fungal) for re-evaluation of employees must occur for each hand immediately following the completion of MFT, but prior to performing any hand hygiene. Testing must be completed at least every 6 months. Additional testing may be required as needed to address possible failures.

Documentation must include at a minimum:

• Employee name

• Evaluation date/time

• Media and components used (manufacturer, lot number, expiration, etc.)

• Incubation temperatures and durations

• Dates of incubation

• Results of the test (CFUs)

• Name of contractor observing test

• Name of contractor observing/documenting results

• Certificate of analysis for media used

B.1. Required Services Per Facility:

mailto:Elizabeth.beatty@va.gov mailto:linda.seely@va.gov mailto:Nicole.patterson1@va.gov

Changes to facility PEC will be communicated in a timely manner to contractor and facility costs will be adjusted accordingly based on these changes. Contractor to provide unit based costs for services to allow for adjustments in equipment.

B.2 Period of Performance: Contract period is from date of award for five (5) years. Performance is to begin 15 calendar days from date of award.

B.3 Special Considerations:

B.3.1 Contractor Furnished Materials:

• All materials and tools to complete the work identified.

• Contractor to ensure all staff that perform on-site testing arrive wearing non-shedding clothing.

• All equipment will be stored and transported by the contractor in a manner that maintains cleanliness of equipment and introduces minimal microorganisms into the clean environments being tested. All equipment will be wiped/cleaned prior to taking into clean testing environments.

B.3.2 Government Furnished Materials and Services:

• The Government will provide all necessary personnel protective equipment (PPE) required for contractors on site.

• The Government will provide oversight and verification of contractor personnel completion of donning of PPE and hand hygiene prior to testing/sampling.

• The Government will, on rare occasion, provide office or meeting space to discuss test results, projects, or plans.

• May also provide desk phone service as needed.

B.3.3 Qualifications/References: GCVHCS is seeking a qualified contractor that meets the following specifications:

• Provide three references showing the completion of at least 3 jobs of similar size and scope at other hospital facilities with at least one of those facilities being a VA Medical Center. Reference information is to include: Hospital/Medical Center name, POC name, email address and phone number.

• All certifications must be signed by an NSF 49 certified technician. A copy of NSF 49 certifications must be attached to the bid documentation for any technicians that will be performing work at the facility.

• All cleanroom performance testing must be supervised by a technician with a CETA National Board of Testing (CNBT) certification. A copy of the certification must be attached to the bid documentation for the supervisor or project manager of the team that will be performing work at the facility.

• Provide AIHA accredited laboratory certification for all USP<797> viable sampling analysis.

Certification must be attached with bid documentation.

• Provide copy of clean room report for evaluation.

• If required, contractor (employees performing services at the facility) will attain VA clearance (i.e.

attend VA training, identification card, etc.)

B.3.4 Security Requirements: There are no security requirements required for this work, as samples are retrieved by the vendor and a test report is received in return.

B.3.5 Additional Considerations The contractor (or Representative) shall contact the facility identified POC(s) to schedule work and prior to the beginning of work. Scheduling of work will be at the direction of facility identified POC(s).

Local facility POC(s) will provide the contractor with additional facility specific procedures which include:

check in and check out procedures; contractor badging requirements; parking procedures; and any additional facility specific procedures. The contractor will be expected to adhere to those procedures. Services are to be performed during the hours between 8:00 AM and 4:00 PM Central Standard Time (CST), Monday through Friday, excluding federal holidays. Due to the workload of the pharmacy during business hours, the contractor may need to work after 4:00 PM CST to accommodate the compounding schedule at the pharmacy. Contractors that are willing to perform after-hours work should include this information in their bid documentation. If a contractor is willing to perform services after 4:00pm (CST) this service must be included within the bid pricing as no extra charge. The ability to perform work after hours is not required; however, preferences will be given to contractors that offer flexible work hours.

B.3.6 Invoicing Payment will be made monthly in arrears, invoices will be prepared by the Contractor, and submitted through .

A properly prepared invoice shall contain:

• Invoice Number and Date

• Contractor’s Name and Address

• Accurate Purchase Order Number

• Supply or Service provided

• Period Supply or Service Provided

• Total Amount Due

The contractor will provide an electronic copy of each invoice to the identified POC(s) referenced in A.3.5.6

B.3.7 Liable Insurance Requirements Contractor must provide proof of liability insurance.

http://www.tungsten-network.com/us/en/

PROJECT TITLE: GLOVE GOWN SAMPLING, USP TESTING (AND OTHER RELATED TESTING)

TASKS/DELIVERABLES “PUNCH LIST” -For Each Performance Period (Base year of 12 months & four (4) option years-each 12 months)

PRICE/COST SCHEDULE (SCHEDULE OF SERVICES) EA=EACH, JB=JOB

ITEM # DESCRIPTION OF SUPPLIES/SERVICES QUANTITY UNIT UNIT PRICE AMOUNT

0001 Contractor to provide personnel and equipment to perform the services listed below:

PROJECT LOCATION 1: Gulf Coast Veterans Health Care System (Biloxi, MS) PROJECT LOCATION 2: JAAC (Pensacola, FL)

TERMS AND CONDITIONS:

In Accordance With (IAW)

• Veterans Affairs, VHA Directive 1108.12, dated November 5, 2018: Management and Monitoring of Pharmaceutical Compounded Sterile Preparations.

• USP General Chapter <797>, Pharmaceutical Compounding- Sterile Preparations, Reprinted from USP 42-NF 37

• Statement of Work (SOW)

1. Certification procedures defined in CETA CAG- 009-00 shall be performed by a CETA National Board of Testing (CNBT) certified testing individual no less than every month.

2. The contractor shall complete viable sampling according to USP <797> (and <800> after December 1, 2019) using certification procedures from the Controlled Environment Testing Association (CETA) Certification Guides for Sterile Compounding Facilities (CAG-009-00).

3. All CSP Facilities must be tested according to CETA CAG-009-00 specifications. The contractor will provide comprehensive cleanroom testing services with frequency required by most current USP <797> standards (and USP <800> after December 1, 2019).

4. Viable particle counts samples will be collected in accordance with applicable CETA guides. Viable samples will be collected for each device (both bacterial and fungal) for the air and surface in accordance with USP <797> (and <800> after December 1, 2019).

1 JB $ $

5. Report Requirements: Results of the certification process will be documented in accordance with CETA guides. All of the following information will be included in the report. Pass/Fail notifications should be included on a per-test basis where applicable.

6. Report Requirements: Comments indicating when dynamic operating conditions were used

7. Report Distribution: A formalized written report including all required aspects specified in this Statement of Work will be provided in a timely manner with receipt by identified points of contact no more than 14 days from certification evaluation.

8. Staff competency testing: All testing must be in accordance with USP <797> (and <800> after December 1, 2019) and CETA CAG-009-00 requirements.

9. Staff competency testing: All employees will complete a Media Fill Test (MFT) using soybean-casein digest media initially upon hiring at least every 6 months. Additional testing may be required as needed to address possible failures.

Manipulation of MFT must be done in a manner that simulates the most difficult compounding completed by each employee.

10. Glove Tip Sampling (bacterial and fungal) for re-evaluation of employees must occur for each hand immediately following the completion of MFT, but prior to performing any hand hygiene. Testing must be completed at least every 6 months. Additional testing may be required as needed to address possible failures.

11. Qualifications/References: All cleanroom performance testing must be supervised by a technician with a CETA National Board of Testing (CNBT) certification. A copy of the certification must be attached to the bid documentation for the supervisor or project manager of the team that will be performing work at the facility.

SEMI-ANNUAL VISITS ARE (2) VISITS -PER

CONTRACTED YEAR, MONTHLY VISITS (1) VISIT PER

MONTH

0002 USP TESTING - GOWNING GLOVE TIP SAMPLING -

BACTERIA - SEMI ANNUAL TESTING

190 EA $ $

SAMPLING IN ACCORDANCE TO CETA CAG-009

SECTION 24 (CURRENT VERSION)

Sampling MUST BE COMPLETED AT LEAST EVERY 6 MONTHS, includes total counts and identification of genus of organism.

BILOXI LOCATION:

(1) TSA sample per hand, per person after successful gowning. Repeat two additional times for a total of (3) complete gowning reviews and (6) samples per person. Total Samples for 8 new employees are (48) samples. This is for initial testing.

(1) TSA sample per hand, per person after successful gowning. Total for 25 employees to be completed twice per year (at least every 6 months) is (50) samples per visit (100) samples annually.

(2) Positive/Negative Control samples required per employee group tested. (152)

PENSACOLA LOCATION:

(1) TSA sample per hand, per person after successful gowning. Repeat two additional times for a total of (3) complete gowning reviews and (6) samples per person. Total for 6 new employees is

(36) samples.

(1) TSA sample per hand, per person after successful gowning. Total for 12 employees to be completed twice per year (at least every 6 months) is (24) samples per visit (48) samples annually.

(2) Positive/Negative Control required per employee group tested.

0003 Contractor will provide personnel and equipment to perform the services listed below:

USP TESTING - GOWNING GLOVE TIP SAMPLING -

FUNGAL - SEMI ANNUAL TESTING SAMPLING IN

ACCORDANCE TO CETA CAG-009 SECTION 24

(CURRENT VERSION)

Sampling MUST BE COMPLETED AT LEAST EVERY 6 MONTHS, includes total counts and identification of genus of organism.

BILOXI LOCATION:

(1) TSA sample per hand, per person after successful gowning. Repeat two additional times for a total of (3) complete gowning reviews and (6) samples per person. Total Samples for 8 new employees is (48) samples. This is for initial testing.

(1) TSA sample per hand, per person after successful gowning. Total for 25 employees to be completed twice per year (at least every 6 months) is (50) samples per visit (100) samples annually.

190 EA $ $

(2) Positive/Negative Control samples required per employee group tested. (152)

PENSACOLA LOCATION:

(1) TSA sample per hand, per person after successful gowning. Repeat two additional times for a total of (3) complete gowning reviews and (6) samples per person. Total for 6 new employees is

(36) samples.

(1) TSA sample per hand, per person after successful gowning. Total for 12 employees to be completed twice per year (at least every 6 months) is (24) samples per visit (48) samples annually.

(2) Positive/Negative Control required per employee group tested.

0004 Contractor will provide personnel and equipment to perform the services listed below:

USP TESTING - VIABLE AIR SAMPLING - BACTERIA -

MONTHLY TESTING: VIABLE AIR SAMPLING FOR

BACTERIA IN ACCORDANCE WITH CETA CAG-009

(CURRENT VERSION)

BILOXI LOCATION:

Sampling locations per trip:

(1) In IV Ante Room

(1) In IV Room

(1) In IV Room Hood

(1) In Chemo Ante Room

(1) In Chemo Room

(1) In Chemo Room Hood

(2) Positive and Negative Control Samples

PENSACOLA LOCATION:

Sampling locations per trip:

(1) In Ante Room

(1) In IV Room

(1) In IV Room Hood

(1) In Chemo Ante Room

(1) In Chemo Room

(1) In Chemo Room Hood

(2) Positive and Negative Control Samples

168 EA $ $

0005 Contractor will provide personnel and equipment to perform the services listed below:

USP TESTING -VIABLE AIR SAMPLING - FUNGAL -

MONTHLY TESTING: VIABLE AIR SAMPLING FOR

FUNGAL IN ACCORDANCE WITH CETA CAG-009

(CURRENT VERSION)

BILOXI LOCATION:

Sampling locations per trip:

(1) In IV Ante Room

(1) In IV Room

168 EA $ $

(1) In IV Room Hood

(1) In Chemo Ante Room

(1) In Chemo Room

(1) In Chemo Room Hood

(2) Positive and Negative Control Samples

PENSACOLA LOCATION:

Sampling locations per trip:

(1) In Ante Room

(1) In IV Room

(1) In IV Room Hood

(1) In Chemo Ante Room

(1) In Chemo Room

(1) In Chemo Room Hood Positive and Negative Control Samples

0006 Contractor will provide personnel and equipment to perform the services listed below:

USP TESTING -VIABLE SURFACE SAMPLING -

BACTERIA - MONTHLY TESTING: VIABLE SURFACE

SAMPLING FOR BACTERIA IN ACCORDANCE WITH

CETA CAG-009 (CURRENT VERSION)

BILOXI LOCATION:

Sampling locations per trip:

(1) In IV Ante Room

(1) In IV Room

(1) In IV Room Hood

(1) In Chemo Ante Room

(1) In Chemo Room

(1) In Chemo Room Hood

PENSACOLA LOCATION: Sampling locations per trip:

(1) In Ante Room

(1) In IV Room

(1) In IV Room Hood

(1) In Chemo Ante Room

(1) In Chemo Room

(1) In Chemo Room Hood

144 EA $138.74 $4,162.20

0007 Contractor will provide personnel and equipment to perform the services listed below:

USP TESTING -VIABLE SURFACE SAMPLING -

FUNGAL - MONTHLY TESTING: VIABLE SURFACE

SAMPLING FOR FUNGAL IN ACCORDANCE WITH

CETA CAG-009 (CURRENT VERSION)

BILOXI LOCATION:

Sampling locations per trip:

(1) In IV Ante Room

(1) In IV Room

(1) In IV Room Hood

(1) In Chemo Ante Room

(1) In Chemo Room

144 EA $ $

(1) In Chemo Room Hood

PENSACOLA LOCATION:

Sampling locations per trip:

(1) In Ante Room

(1) In IV Room

(1) In IV Room Hood

(1) In Chemo Ante Room

(1) In Chemo Room

(1) In Chemo Room Hood

0008 TRAVEL - BILOXI, MS

TRAVEL/LODGING/MEALS CNBT TECHNICIAN

Travel Rate: The Travel Rate will be calculated at a specified dollar amount per hour round trip from the nearest CNBT Accredited Technician.

1 JB $ $

0009 TRAVEL/LODGING - PENSACOLA, FL

TRAVEL/LODGING/MEALS CNBT TECHNICIAN

Travel Rate: The Travel Rate will be calculated at a specified dollar amount per hour round trip from nearest CNBT Accredited Technician.

1 JB $ $

0010 REPORT GENERATION FEE - BILOXI

ONE FEE PER VISIT PER SITE

12 EA $ $

0011 REPORT GENERATION FEE - PENSACOLA, FL

ONE FEE PER VISIT PER SITE

12 EA $ $

0012 OVERNIGHT FREIGHT- OVERNIGHT FEE FOR

EXTERNAL LAB ANALYSIS

OVERNIGHT FREIGHT - SHIPPING OF SAMPLES TO

LAB FOR ANALYSIS FOR BOTH BILOXI, MS AND

PENSACOLA, FL SITES.

24 EA $ $

0013 MEDIUM BASIC (VIALS ONLY) MEDIA FILL KITS-

PENSACOLA, FL

35 EA $ $

0014 USP TESTING -REPORT GENERATION- MEDIA FILL

TESTING REPORT - PENSACOLA, FL

ONE FEE PER VISIT, PER SITE

2 EA $ $

0015 MEDIUM BASIC (VIALS ONLY) MEDIA FILL KITS-

BILOXI, MS

60 EA $ $

0016 USP TESTING -REPORT GENERATION- MEDIA FILL

TESTING REPORT - BILOXI, MS

ONE FEE PER SITE, PER VISIT

2 EA $ $

GRAND

TOTAL

See attached document: USP 797 (2019) Highlight.

See attached document: VA Directive 1108.12 CETA Highlight.